Cargando…
Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
OBJECTIVES: To analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS). MATERIALS AND METHODS: Between 1999 and 2020, breast cancer patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436470/ https://www.ncbi.nlm.nih.gov/pubmed/37601676 http://dx.doi.org/10.3389/fonc.2023.1217869 |
_version_ | 1785092332976078848 |
---|---|
author | Liu, Gang Xing, Zeyu Guo, Changyuan Dai, Qichen Cheng, Han Wang, Xiang Tang, Yu Wang, Yipeng |
author_facet | Liu, Gang Xing, Zeyu Guo, Changyuan Dai, Qichen Cheng, Han Wang, Xiang Tang, Yu Wang, Yipeng |
author_sort | Liu, Gang |
collection | PubMed |
description | OBJECTIVES: To analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS). MATERIALS AND METHODS: Between 1999 and 2020, breast cancer patients meeting inclusion criteria of unilateral, no distant metastatic site, and T1 invasive ductal carcinoma were reviewed. Clinical pathology characteristics were retrieved from medical records. Survival analysis was performed using Kaplan−Meier methods and an adjusted Cox proportional hazards model. RESULTS: We enrolled 11,407 eligible patients as a discovery cohort to explore risk factors for LNM and 3484 patients with stage T1N0 as a survival analysis cohort to identify the effect of those risk factors on OS and DFS. Compared with patients with N- status, patients with N+ status had a younger age, larger tumor size, higher Ki67 level, higher grade, higher HR+ and HER2+ percentages, and higher luminal B and HER2-positive subtype percentages. Logistic regression indicated that age was a protective factor and tumor size/higher grade/HR+ and HER2+ risk factors for LNM. Compared with limited LNM (N1) patients, extensive LNM (N2/3) patients had larger tumor sizes, higher Ki67 levels, higher grades, higher HR- and HER2+ percentages, and lower luminal A subtype percentages. Logistic regression indicated that HR+ was a protective factor and tumor size/higher grade/HER2+ risk factors for extensive LNM. Kaplan−Meier analysis indicated that grade was a predictor of both OS and DFS; HR was a predictor of OS but not DFS. Multivariate survival analysis using the Cox regression model demonstrated age and Ki67 level to be predictors of OS and grade and HER2 status of DFS in stage T1N0 patients. CONCLUSION: In T1 breast cancer patients, there were several differences between N- and N+ patients, limited LNM and extensive LNM patients. Besides, HR+ plays a dual role in regional LNM. In patients without LNM, age and Ki67 level are predictors of OS, and grade and HER2 are predictors of DFS. |
format | Online Article Text |
id | pubmed-10436470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104364702023-08-19 Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study Liu, Gang Xing, Zeyu Guo, Changyuan Dai, Qichen Cheng, Han Wang, Xiang Tang, Yu Wang, Yipeng Front Oncol Oncology OBJECTIVES: To analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS). MATERIALS AND METHODS: Between 1999 and 2020, breast cancer patients meeting inclusion criteria of unilateral, no distant metastatic site, and T1 invasive ductal carcinoma were reviewed. Clinical pathology characteristics were retrieved from medical records. Survival analysis was performed using Kaplan−Meier methods and an adjusted Cox proportional hazards model. RESULTS: We enrolled 11,407 eligible patients as a discovery cohort to explore risk factors for LNM and 3484 patients with stage T1N0 as a survival analysis cohort to identify the effect of those risk factors on OS and DFS. Compared with patients with N- status, patients with N+ status had a younger age, larger tumor size, higher Ki67 level, higher grade, higher HR+ and HER2+ percentages, and higher luminal B and HER2-positive subtype percentages. Logistic regression indicated that age was a protective factor and tumor size/higher grade/HR+ and HER2+ risk factors for LNM. Compared with limited LNM (N1) patients, extensive LNM (N2/3) patients had larger tumor sizes, higher Ki67 levels, higher grades, higher HR- and HER2+ percentages, and lower luminal A subtype percentages. Logistic regression indicated that HR+ was a protective factor and tumor size/higher grade/HER2+ risk factors for extensive LNM. Kaplan−Meier analysis indicated that grade was a predictor of both OS and DFS; HR was a predictor of OS but not DFS. Multivariate survival analysis using the Cox regression model demonstrated age and Ki67 level to be predictors of OS and grade and HER2 status of DFS in stage T1N0 patients. CONCLUSION: In T1 breast cancer patients, there were several differences between N- and N+ patients, limited LNM and extensive LNM patients. Besides, HR+ plays a dual role in regional LNM. In patients without LNM, age and Ki67 level are predictors of OS, and grade and HER2 are predictors of DFS. Frontiers Media S.A. 2023-08-04 /pmc/articles/PMC10436470/ /pubmed/37601676 http://dx.doi.org/10.3389/fonc.2023.1217869 Text en Copyright © 2023 Liu, Xing, Guo, Dai, Cheng, Wang, Tang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Liu, Gang Xing, Zeyu Guo, Changyuan Dai, Qichen Cheng, Han Wang, Xiang Tang, Yu Wang, Yipeng Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title | Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title_full | Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title_fullStr | Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title_full_unstemmed | Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title_short | Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study |
title_sort | identifying clinicopathological risk factors for regional lymph node metastasis in chinese patients with t1 breast cancer: a population-based study |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436470/ https://www.ncbi.nlm.nih.gov/pubmed/37601676 http://dx.doi.org/10.3389/fonc.2023.1217869 |
work_keys_str_mv | AT liugang identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT xingzeyu identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT guochangyuan identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT daiqichen identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT chenghan identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT wangxiang identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT tangyu identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy AT wangyipeng identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy |